vs
Side-by-side financial comparison of POTLATCHDELTIC CORP (PCH) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $314.2M, roughly 2.0× POTLATCHDELTIC CORP). Royalty Pharma plc runs the higher net margin — 34.4% vs 8.2%, a 26.2% gap on every dollar of revenue. On growth, POTLATCHDELTIC CORP posted the faster year-over-year revenue change (23.1% vs 4.8%). Over the past eight quarters, POTLATCHDELTIC CORP's revenue compounded faster (11.1% CAGR vs 4.6%).
POTLATCHDELTIC CORPPCHEarnings & Financial Report
PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
PCH vs RPRX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $314.2M | $622.0M |
| Net Profit | $25.9M | $214.2M |
| Gross Margin | 18.2% | — |
| Operating Margin | 11.2% | 62.4% |
| Net Margin | 8.2% | 34.4% |
| Revenue YoY | 23.1% | 4.8% |
| Net Profit YoY | 682.5% | 2.9% |
| EPS (diluted) | $0.33 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $622.0M | ||
| Q3 25 | $314.2M | $609.3M | ||
| Q2 25 | $275.0M | $578.7M | ||
| Q1 25 | $268.3M | $568.2M | ||
| Q4 24 | $258.1M | $593.6M | ||
| Q3 24 | $255.1M | $564.7M | ||
| Q2 24 | $320.7M | $537.3M | ||
| Q1 24 | $228.1M | $568.0M |
| Q4 25 | — | $214.2M | ||
| Q3 25 | $25.9M | $288.2M | ||
| Q2 25 | $7.4M | $30.2M | ||
| Q1 25 | $25.8M | $238.3M | ||
| Q4 24 | $5.2M | $208.2M | ||
| Q3 24 | $3.3M | $544.0M | ||
| Q2 24 | $13.7M | $102.0M | ||
| Q1 24 | $-305.0K | $4.8M |
| Q4 25 | — | — | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 17.8% | — | ||
| Q4 24 | 13.4% | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 11.9% | — | ||
| Q1 24 | 7.0% | — |
| Q4 25 | — | 62.4% | ||
| Q3 25 | 11.2% | 70.1% | ||
| Q2 25 | 5.0% | 36.3% | ||
| Q1 25 | 10.3% | 94.0% | ||
| Q4 24 | 5.2% | 60.9% | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 5.4% | 50.2% | ||
| Q1 24 | -2.1% | -13.0% |
| Q4 25 | — | 34.4% | ||
| Q3 25 | 8.2% | 47.3% | ||
| Q2 25 | 2.7% | 5.2% | ||
| Q1 25 | 9.6% | 41.9% | ||
| Q4 24 | 2.0% | 35.1% | ||
| Q3 24 | 1.3% | 96.3% | ||
| Q2 24 | 4.3% | 19.0% | ||
| Q1 24 | -0.1% | 0.8% |
| Q4 25 | — | $0.49 | ||
| Q3 25 | $0.33 | $0.67 | ||
| Q2 25 | $0.09 | $0.07 | ||
| Q1 25 | $0.33 | $0.55 | ||
| Q4 24 | $0.07 | $0.46 | ||
| Q3 24 | $0.04 | $1.21 | ||
| Q2 24 | $0.17 | $0.23 | ||
| Q1 24 | $0.00 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $88.8M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $1.9B | $9.7B |
| Total Assets | $3.2B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $618.7M | ||
| Q3 25 | $88.8M | $938.9M | ||
| Q2 25 | $95.3M | $631.9M | ||
| Q1 25 | $147.5M | $1.1B | ||
| Q4 24 | $151.6M | $929.0M | ||
| Q3 24 | $161.1M | $950.1M | ||
| Q2 24 | $199.7M | $1.8B | ||
| Q1 24 | $180.2M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $1.0B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | — | $9.7B | ||
| Q3 25 | $1.9B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $2.0B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $2.1B | $10.3B | ||
| Q2 24 | $2.1B | $9.8B | ||
| Q1 24 | $2.2B | $9.9B |
| Q4 25 | — | $19.6B | ||
| Q3 25 | $3.2B | $19.3B | ||
| Q2 25 | $3.2B | $18.3B | ||
| Q1 25 | $3.3B | $17.6B | ||
| Q4 24 | $3.3B | $18.2B | ||
| Q3 24 | $3.3B | $18.0B | ||
| Q2 24 | $3.4B | $17.7B | ||
| Q1 24 | $3.4B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.51× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $65.7M | $827.1M |
| Free Cash FlowOCF − Capex | $50.1M | — |
| FCF MarginFCF / Revenue | 15.9% | — |
| Capex IntensityCapex / Revenue | 4.9% | — |
| Cash ConversionOCF / Net Profit | 2.54× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $132.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $827.1M | ||
| Q3 25 | $65.7M | $702.6M | ||
| Q2 25 | $41.0M | $364.0M | ||
| Q1 25 | $49.1M | $596.1M | ||
| Q4 24 | $45.4M | $742.5M | ||
| Q3 24 | $26.5M | $703.6M | ||
| Q2 24 | $100.6M | $658.2M | ||
| Q1 24 | $16.0M | $664.6M |
| Q4 25 | — | — | ||
| Q3 25 | $50.1M | — | ||
| Q2 25 | $30.6M | — | ||
| Q1 25 | $26.3M | — | ||
| Q4 24 | $25.4M | — | ||
| Q3 24 | $-8.2M | — | ||
| Q2 24 | $72.4M | — | ||
| Q1 24 | $2.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 9.8% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | -3.2% | — | ||
| Q2 24 | 22.6% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 7.7% | — | ||
| Q3 24 | 13.6% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 6.1% | — |
| Q4 25 | — | 3.86× | ||
| Q3 25 | 2.54× | 2.44× | ||
| Q2 25 | 5.58× | 12.06× | ||
| Q1 25 | 1.90× | 2.50× | ||
| Q4 24 | 8.74× | 3.57× | ||
| Q3 24 | 7.99× | 1.29× | ||
| Q2 24 | 7.35× | 6.45× | ||
| Q1 24 | — | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PCH
| Lumber | $131.8M | 42% |
| Timberlands | $52.5M | 17% |
| Rural Real Estate | $51.3M | 16% |
| Residuals And Panels | $34.0M | 11% |
| Pulpwood | $16.7M | 5% |
| Development Real Estate | $14.6M | 5% |
| Other | $8.1M | 3% |
| Other Products | $5.2M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
